Good evening :)
Place Order
Add to Watchlist

Indrayani Biotech Ltd

INDRANIB Share Price

14.070.79% (+0.11)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹64 cr, stock is ranked 3,445

Stock is 3.31x as volatile as Nifty

INDRANIB Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹64 cr, stock is ranked 3,445

Stock is 3.31x as volatile as Nifty

INDRANIB Performance & Key Metrics

INDRANIB Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-15.580.84
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
28.367.722.57%

INDRANIB Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

INDRANIB Company Profile

Indrayani Biotech is engaged in providing travel technology and solutions.

INDRANIB Similar Stocks (Peers)

Compare with peers Compare with peers 

INDRANIB Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
61.95
61.95
1Y Return
16.02%
16.02%
Buy Reco %
51.61
51.61
PE Ratio
32.19
32.19
1Y Return
20.54%
20.54%
Buy Reco %
100.00
100.00
PE Ratio
36.37
36.37
1Y Return
10.70%
10.70%
Buy Reco %
45.83
45.83
PE Ratio
50.08
50.08
1Y Return
9.82%
9.82%
Buy Reco %
8.33
8.33
PE Ratio
49.43
49.43
1Y Return
8.15%
8.15%
Buy Reco %
50.00
50.00
Compare with Peers

INDRANIB Forecast

INDRANIB Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

INDRANIB

INDRANIB

Income

Balance Sheet

Cash Flow

INDRANIB Income Statement

INDRANIB Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 21.63%, vs industry avg of 13.64%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.13% to 0.18%

Loading...

Financial YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue50.1021.3661.79167.42167.44133.35133.35
Raw Materialssubtract32.4815.7741.04102.2197.13123.97123.97
Power & Fuel Costsubtract0.480.330.346.086.70
Employee Costsubtract10.815.399.5823.0123.07
Selling & Administrative Expensessubtract2.093.602.697.776.73
Operating & Other expensessubtract1.265.051.157.048.94
Depreciation/Amortizationsubtract1.010.460.663.353.803.373.36
Interest & Other Itemssubtract1.151.971.895.6410.1011.7611.77
Taxes & Other Itemssubtract0.000.000.003.564.61-1.22-1.64
EPS2.25-5.921.302.561.59-1.35-0.90
DPS0.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.00

INDRANIB Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

INDRANIB Stock Peers

INDRANIB Past Performance & Peer Comparison

INDRANIB Past Performance & Peer Comparison

Comparing 3 stocks from 
Information TechnologySoftware Services

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Indrayani Biotech Ltd-14.130.84
Persistent Systems Ltd61.9513.730.63%
Oracle Financial Services Software Ltd32.199.163.01%
L&T Technology Services Ltd36.377.551.26%

INDRANIB Stock Price Comparison

Compare INDRANIB with any stock or ETF
Compare INDRANIB with any stock or ETF
INDRANIB
Loading...

INDRANIB Holdings

INDRANIB Shareholdings

INDRANIB Promoter Holdings Trend

INDRANIB Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

INDRANIB Institutional Holdings Trend

INDRANIB Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

INDRANIB Shareholding Pattern

INDRANIB Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding33.28%0.00%3.66%0.00%63.06%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

INDRANIB Shareholding History

INDRANIB Shareholding History

MarAprJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

INDRANIB Insider Trades & Bulk Stock Deals

INDRANIB Insider Trades & Bulk Stock Deals

Loading...

smallcases containing INDRANIB stock

smallcases containing INDRANIB stock

Looks like this stock is not in any smallcase yet.

INDRANIB Events

INDRANIB Events

INDRANIB Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

INDRANIB has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

INDRANIB Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

INDRANIB has not given any dividends in last 5 years

INDRANIB Dividends

INDRANIB Dividends

Hmm, looks like data is unavailable here. Please come back after some time

INDRANIB Stock News & Opinions

INDRANIB Stock News & Opinions

Earnings
Indrayani Biotech reports consolidated net loss of Rs 5.81 crore in the March 2025 quarter

Net loss of Indrayani Biotech reported to Rs 5.81 crore in the quarter ended March 2025 as against net profit of Rs 3.87 crore during the previous quarter ended March 2024. Sales rose 13.95% to Rs 50.57 crore in the quarter ended March 2025 as against Rs 44.38 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 4.52 crore in the year ended March 2025 as against net profit of Rs 6.36 crore during the previous year ended March 2024. Sales declined 21.66% to Rs 130.23 crore in the year ended March 2025 as against Rs 166.23 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales50.5744.38 14 130.23166.23 -22 OPM %-11.3522.94 -4.8114.11 - PBDT-10.035.69 PL -2.3814.78 PL PBT-8.324.73 PL -5.7410.97 PL NP-5.813.87 PL -4.526.36 PL Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Earnings
Indrayani Biotech standalone net profit rises 1485.71% in the March 2025 quarter

Net profit of Indrayani Biotech rose 1485.71% to Rs 1.11 crore in the quarter ended March 2025 as against Rs 0.07 crore during the previous quarter ended March 2024. Sales declined 41.27% to Rs 9.28 crore in the quarter ended March 2025 as against Rs 15.80 crore during the previous quarter ended March 2024. For the full year,net profit declined 0.68% to Rs 1.45 crore in the year ended March 2025 as against Rs 1.46 crore during the previous year ended March 2024. Sales declined 39.39% to Rs 37.77 crore in the year ended March 2025 as against Rs 62.32 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales9.2815.80 -41 37.7762.32 -39 OPM %18.536.27 -14.489.10 - PBDT0.261.97 -87 1.674.46 -63 PBT0.201.62 -88 0.653.01 -78 NP1.110.07 1486 1.451.46 -1 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Indrayani Biotech adjourns board meeting

Indrayani Biotech has adjourned the meeting of the Board of Directors which was scheduled to be held on 9 June 2025. The meeting will now be held on 12 June 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Indrayani Biotech to discuss results

Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 9 June 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Indrayani Biotech to consider right Issue

Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 3 April 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Indrayani Biotech consolidated net profit declines 75.51% in the December 2024 quarter

Net profit of Indrayani Biotech declined 75.51% to Rs 0.24 crore in the quarter ended December 2024 as against Rs 0.98 crore during the previous quarter ended December 2023. Sales declined 55.69% to Rs 17.32 crore in the quarter ended December 2024 as against Rs 39.09 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales17.3239.09 -56 OPM %16.868.80 - PBDT1.892.12 -11 PBT0.431.08 -60 NP0.240.98 -76 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Indrayani Biotech to discuss results

Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Indrayani Biotech consolidated net profit declines 77.98% in the September 2024 quarter

Net profit of Indrayani Biotech declined 77.98% to Rs 1.22 crore in the quarter ended September 2024 as against Rs 5.54 crore during the previous quarter ended September 2023. Sales declined 23.81% to Rs 30.81 crore in the quarter ended September 2024 as against Rs 40.44 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales30.8140.44 -24 OPM %16.5918.05 - PBDT3.996.45 -38 PBT1.205.54 -78 NP1.225.54 -78 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Indrayani Biotech to table results

Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Earnings
Indrayani Biotech reports consolidated net profit of Rs 0.85 crore in the June 2024 quarter

Net profit of Indrayani Biotech reported to Rs 0.85 crore in the quarter ended June 2024 as against net loss of Rs 0.45 crore during the previous quarter ended June 2023. Sales declined 25.48% to Rs 31.53 crore in the quarter ended June 2024 as against Rs 42.31 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales31.5342.31 -25 OPM %12.625.98 - PBDT1.770.52 240 PBT0.94-0.38 LP NP0.85-0.45 LP Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Indrayani Biotech Ltd (INDRANIB) today?

    The share price of INDRANIB as on 16th July 2025 is ₹14.07. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Indrayani Biotech Ltd (INDRANIB) share?

    The past returns of Indrayani Biotech Ltd (INDRANIB) share are
    • Past 1 week: -10.05%
    • Past 1 month: -9.29%
    • Past 3 months: -29.65%
    • Past 6 months: -58.86%
    • Past 1 year: -73.55%
    • Past 3 years: -68.02%
    • Past 5 years: 67.90%

  3. What are the peers or stocks similar to Indrayani Biotech Ltd (INDRANIB)?
  4. What is the market cap of Indrayani Biotech Ltd (INDRANIB) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indrayani Biotech Ltd (INDRANIB) is ₹64.02 Cr as of 16th July 2025.

  5. What is the 52 week high and low of Indrayani Biotech Ltd (INDRANIB) share?

    The 52-week high of Indrayani Biotech Ltd (INDRANIB) is ₹60.50 and the 52-week low is ₹13.01.

  6. What is the PE and PB ratio of Indrayani Biotech Ltd (INDRANIB) stock?

    The P/E (price-to-earnings) ratio of Indrayani Biotech Ltd (INDRANIB) is -14.13. The P/B (price-to-book) ratio is 0.84.

  7. Which sector does Indrayani Biotech Ltd (INDRANIB) belong to?

    Indrayani Biotech Ltd (INDRANIB) belongs to the Information Technology sector & Software Services sub-sector.

  8. How to buy Indrayani Biotech Ltd (INDRANIB) shares?

    You can directly buy Indrayani Biotech Ltd (INDRANIB) shares on Tickertape. Simply sign up, connect your demat account and place your order.